These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1582007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N, Siegfried M, Tsao P, Lento P, Lefer AM.
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion.
    Carey C, Siegfried MR, Ma XL, Weyrich AS, Lefer AM.
    Circ Shock; 1992 Nov; 38(3):209-16. PubMed ID: 1292885
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H, Smith BA, Lefer AM.
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
    Karasawa A, Guo JP, Ma XL, Lefer AM.
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297
    [Abstract] [Full Text] [Related]

  • 11. Protective actions of a leukotriene B4 antagonist in splanchnic ischemia and reperfusion in rats.
    Karasawa A, Guo JP, Ma XL, Tsao PS, Lefer AM.
    Am J Physiol; 1991 Aug; 261(2 Pt 1):G191-8. PubMed ID: 1651656
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C.
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N, Johnson G, Siegfried MR, Lefer AM.
    Eicosanoids; 1989 Jul; 2(3):169-74. PubMed ID: 2534278
    [Abstract] [Full Text] [Related]

  • 19. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
    Furlan LE, Johnson G, Siegfried M, Lefer AM.
    J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129
    [Abstract] [Full Text] [Related]

  • 20. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL.
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.